GetTopicDetailResponse(id=70c2e71625b, topicName=紅細(xì)胞成熟劑, introduction=紅細(xì)胞成熟劑, content=null, image=null, comments=3, allHits=1401, url=https://h5.medsci.cn/topic?id=77162, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=88543, tagList=[TagDto(tagId=88543, tagName=紅細(xì)胞成熟劑)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2162510, encodeId=e7af2162510bd, content=<a href='/topic/show?id=2e9d1069364b' target=_blank style='color:#2F92EE;'>#羅特西普#</a>是一種<a href='/topic/show?id=70c2e71625b' target=_blank style='color:#2F92EE;'>#紅細(xì)胞成熟劑#</a>，用于低危的<a href='/topic/show?id=fab3101964cd' target=_blank style='color:#2F92EE;'>#骨髓增生異常綜合征#</a> , objectTitle=【Leukemia】羅特西普治療較低危MDS伴環(huán)形鐵粒幼紅細(xì)胞的39.9個月隨訪結(jié)果, objectType=article, longId=795753, objectId=548ae9575369, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668016274166_4754896.png, objectUrl=/article/show_article.do?id=548ae9575369, replyNumber=0, likeNumber=155, createdTime=2023-10-13, rootId=0, userName=俠膽醫(yī)心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=548ae9575369, moduleTitle=【Leukemia】羅特西普治療較低危MDS伴環(huán)形鐵粒幼紅細(xì)胞的39.9個月隨訪結(jié)果, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=548ae9575369)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997225, encodeId=4659199e2252f, content=<a href='/topic/show?id=70c2e71625b' target=_blank style='color:#2F92EE;'>#紅細(xì)胞成熟劑#</a>, objectTitle=歐盟批準(zhǔn)紅細(xì)胞成熟劑Reblozyl，治療輸血依賴性貧血, objectType=article, longId=196866, objectId=ef0319686621, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef0319686621, replyNumber=0, likeNumber=93, createdTime=2020-10-10, rootId=0, userName=wjywjy, userId=1072181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef0319686621, moduleTitle=歐盟批準(zhǔn)紅細(xì)胞成熟劑Reblozyl，治療輸血依賴性貧血, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=ef0319686621)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1997224, encodeId=5abf199e224dc, content=<a href='/topic/show?id=70c2e71625b' target=_blank style='color:#2F92EE;'>#紅細(xì)胞成熟劑#</a>, objectTitle=Celgene向FDA提交紅細(xì)胞成熟劑luspatercept的申請, objectType=article, longId=163897, objectId=38d416389e04, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=38d416389e04, replyNumber=0, likeNumber=96, createdTime=2019-07-23, rootId=0, userName=wjywjy, userId=1072181, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=38d416389e04, moduleTitle=Celgene向FDA提交紅細(xì)胞成熟劑luspatercept的申請, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=38d416389e04)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
